In recent years, TRPM2 has been shown to be involved in the pathophysiology of ischemic stroke in all the aspects, including accelerating the development of upstream risk factors outside the brain and aggregating the post-stroke pathological damage inside the brain. The gene discussed is TRPM2; the disease is stroke disorder.